BE644705A - - Google Patents

Info

Publication number
BE644705A
BE644705A BE644705A BE644705A BE644705A BE 644705 A BE644705 A BE 644705A BE 644705 A BE644705 A BE 644705A BE 644705 A BE644705 A BE 644705A BE 644705 A BE644705 A BE 644705A
Authority
BE
Belgium
Application number
BE644705A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US262846A external-priority patent/US3192200A/en
Application filed filed Critical
Publication of BE644705A publication Critical patent/BE644705A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C07D243/26—Preparation from compounds already containing the benzodiazepine skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE644705A 1963-03-05 1964-03-04 BE644705A (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US262846A US3192200A (en) 1963-03-05 1963-03-05 1-cycloalkyl methyl derivatives of 1, 4-benzodiazepine
US410790A US3326757A (en) 1963-03-05 1964-11-12 Compositions and method for producing skeletal muscle relaxation

Publications (1)

Publication Number Publication Date
BE644705A true BE644705A (en:Method) 1964-09-04

Family

ID=26949494

Family Applications (1)

Application Number Title Priority Date Filing Date
BE644705A BE644705A (en:Method) 1963-03-05 1964-03-04

Country Status (8)

Country Link
US (1) US3326757A (en:Method)
BE (1) BE644705A (en:Method)
BR (1) BR6457243D0 (en:Method)
CH (1) CH427830A (en:Method)
DE (1) DE1470422A1 (en:Method)
FR (1) FR3452M (en:Method)
GB (1) GB1029741A (en:Method)
SE (1) SE309779B (en:Method)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8778264B2 (en) 2010-10-28 2014-07-15 Guy L. McClung, III Fluid treatment systems
US8911676B2 (en) 2010-10-21 2014-12-16 Guy L. McClung, III Treatment systems for fluids

Also Published As

Publication number Publication date
BR6457243D0 (pt) 1973-07-17
US3326757A (en) 1967-06-20
FR3452M (fr) 1965-07-26
SE309779B (en:Method) 1969-04-08
DE1470422A1 (de) 1969-11-13
CH427830A (de) 1967-01-15
GB1029741A (en) 1966-05-18

Similar Documents

Publication Publication Date Title
AR142945A1 (en:Method)
BE627012A (en:Method)
BE621517A (en:Method)
BE645267A (en:Method)
BE627023A (en:Method)
BE627145A (en:Method)
BE643231A (en:Method)
BE626915A (en:Method)
BE465565A (en:Method)
BE644247A (en:Method)
BE626358A (en:Method)
BE625880A (en:Method)
BE626826A (en:Method)
BE507458A (en:Method)
BE621232A (en:Method)
BE462764A (en:Method)
BE31062A (en:Method)
BE603935A (en:Method)
BE625136A (en:Method)
BE642309A (en:Method)
BE643753A (en:Method)
BE533484A (en:Method)
BE645398A (en:Method)
BE627151A (en:Method)
BE627172A (en:Method)